Your browser doesn't support javascript.
loading
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.
Kohlhaas, Vivien; Blakemore, Stuart James; Al-Maarri, Mona; Nickel, Nadine; Pal, Martin; Roth, Andreas; Hövelmeyer, Nadine; Schäfer, Stephan C; Knittel, Gero; Lohneis, Philipp; Nikolic, Milos; Wiederstein, Janica L; Franitza, Marek; Georgomonolis, Theodoros; Reinart, Nina; Herling, Marco; Herling, Carmen; Hartmann, Elena M; Rosenwald, Andreas; Klapper, Wolfram; Büttner, Reinhard; Moia, Riccardo; Rossi, Davide; Boldorini, Renzo; Gaidano, Gianluca; Frenzel, Lukas P; Reinhardt, Hans Christian; Brüning, Jens C; Hallek, Michael; Krüger, Marcus; Peifer, Martin; Pallasch, Christian P; Wunderlich, F Thomas.
Afiliación
  • Kohlhaas V; Max Planck Institute for Metabolism Research, Cologne, Germany.
  • Blakemore SJ; Institute for Genetics, University of Cologne, Cologne, Germany.
  • Al-Maarri M; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
  • Nickel N; Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
  • Pal M; Center for Endocrinology, Diabetes and Preventive Medicine (CEDP) Cologne, Cologne, Germany.
  • Roth A; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
  • Hövelmeyer N; Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
  • Schäfer SC; Department I of Internal Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Knittel G; Max Planck Institute for Metabolism Research, Cologne, Germany.
  • Lohneis P; Institute for Genetics, University of Cologne, Cologne, Germany.
  • Nikolic M; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
  • Wiederstein JL; Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
  • Franitza M; Center for Endocrinology, Diabetes and Preventive Medicine (CEDP) Cologne, Cologne, Germany.
  • Georgomonolis T; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
  • Reinart N; Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
  • Herling M; Department I of Internal Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Herling C; Max Planck Institute for Metabolism Research, Cologne, Germany.
  • Hartmann EM; Institute for Genetics, University of Cologne, Cologne, Germany.
  • Rosenwald A; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
  • Klapper W; Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
  • Büttner R; Center for Endocrinology, Diabetes and Preventive Medicine (CEDP) Cologne, Cologne, Germany.
  • Moia R; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
  • Rossi D; Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
  • Boldorini R; Department I of Internal Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Gaidano G; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg, University Mainz, Mainz, Germany.
  • Frenzel LP; Institute of Pathology.
  • Reinhardt HC; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
  • Brüning JC; Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
  • Hallek M; Department I of Internal Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Krüger M; Institute of Pathology.
  • Peifer M; Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
  • Pallasch CP; Department of Translational Genomics, and.
  • Wunderlich FT; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
Blood ; 137(5): 646-660, 2021 02 04.
Article en En | MEDLINE | ID: mdl-33538798
ABSTRACT
Richter's transformation (RT) is an aggressive lymphoma that occurs upon progression from chronic lymphocytic leukemia (CLL). Transformation has been associated with genetic aberrations in the CLL phase involving TP53, CDKN2A, MYC, and NOTCH1; however, a significant proportion of RT cases lack CLL phase-associated events. Here, we report that high levels of AKT phosphorylation occur both in high-risk CLL patients harboring TP53 and NOTCH1 mutations as well as in patients with RT. Genetic overactivation of Akt in the murine Eµ-TCL1 CLL mouse model resulted in CLL transformation to RT with significantly reduced survival and an aggressive lymphoma phenotype. In the absence of recurrent mutations, we identified a profile of genomic aberrations intermediate between CLL and diffuse large B-cell lymphoma. Multiomics assessment by phosphoproteomic/proteomic and single-cell transcriptomic profiles of this Akt-induced murine RT revealed an S100 protein-defined subcluster of highly aggressive lymphoma cells that developed from CLL cells, through activation of Notch via Notch ligand expressed by T cells. Constitutively active Notch1 similarly induced RT of murine CLL. We identify Akt activation as an initiator of CLL transformation toward aggressive lymphoma by inducing Notch signaling between RT cells and microenvironmental T cells.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia Linfocítica Crónica de Células B / Linfoma de Células B Grandes Difuso / Proteínas Proto-Oncogénicas c-akt / Receptor Notch1 / Proteínas de Neoplasias Límite: Animals Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia Linfocítica Crónica de Células B / Linfoma de Células B Grandes Difuso / Proteínas Proto-Oncogénicas c-akt / Receptor Notch1 / Proteínas de Neoplasias Límite: Animals Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article País de afiliación: Alemania